Amine-reactive ova multimers for auto-vaccination against cytokines and other mediators: Perspectives illustrated for GCP-2 in l. major infection

Journal of Leukocyte Biology

Volumn 89, Issue 6, 2011, Pages 1001-1007

  Uyttenhove, Catherine ^a,b   Marillier, Reece G ^a,c   Tacchini Cottier, Fabienne ^e   Charmoy, Melanie ^e   Caspi, Rachel R ^d   Damsker, Jesse M ^d   Goriely, Stanislas ^b   Su, Dan ^c   Van Damme, Jo ^f   Struyf, Sofie ^f   Opdenakker, Ghislain ^f   van Snick, Jacques ^a,c  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^b Cellular Genetics Unit   (Belgium)

^c DE DUVE INSTITUTE   (Belgium)

^d UNIVERSITY OF LAUSANNE   (Switzerland)

^e NATIONAL EYE INSTITUTE   (United States)

^f REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Antigen; Chemokine; Cross linking; Interleukin; Vaccine

Indexed keywords

AMINE; GELATINASE B; GELATINASE B ANTIBODY; GLUTARALDEHYDE; GRANULOCYTE CHEMOTACTIC PROTEIN 2; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17F; INTERLEUKIN 25; INTERLEUKIN 27; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY GRANULOCYTE CHEMOTACTIC PROTEIN 2; OVALBUMIN; POLYMER; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; GEL PERMEATION CHROMATOGRAPHY; IMMUNIZATION; IMMUNOGENICITY; LEISHMANIASIS; MOUSE; NEUTROPHIL; NONHUMAN; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN TARGETING; VACCINATION;

AMINES; ANIMALS; CELL MOVEMENT; CHEMOKINES; CYTOKINES; GLUTARAL; IMMUNIZATION; INTERLEUKIN-17; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEUTROPHILS; OVALBUMIN; PROTEIN MULTIMERIZATION;

LEISHMANIA MAJOR; MUS;

EID: 79957865717     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1210699     Document Type: Article

References (35)

1. Ratsimandresy, R. A., Rappaport, J., Zagury, J. F. (2009) Anti-cytokine therapeutics: history and update. Curr. Pharm. Des. 15, 1998-2025.
2. Johnson, H. E., DeAvila, D. M., Chang, C. F., Reeves, J. J. (1988) Active immunization of heifers against luteinizing hormone-releasing hormone, human chorionic gonadotropin and bovine luteinizing hormone. J. Anim. Sci. 66, 719-726.
3. Dalum, I., Butler, D. M., Jensen, M. R, Hindersson, P., Steinaa, L., Wa-terston, A. M., Grell, S. N., Feldmann, M., Elsner, H. I., Mouritsen, S. (1999) Therapeutic antibodies elicited by immunization against TNF-α. Nat. Biotechnol. 17, 666-669.
4. Chackerian, B., Lowy, D. R, Schiller, J. T. (2001) Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies. J. Clin. Invest. 108, 415-423.
5. Dalum, I., Jensen, M. R, Hindersson, P., Elsner, H. I., Mouritsen, I. (1996) Breaking of B cell tolerance toward a highly conserved self protein. J. Immunol. 157, 4796-4804.
6. Spohn, G., Keller, I., Beck, M., Grest, P., Jennings, G. T., Bachmann, M. F. (2008) Active immunization with IL-1 displayed on virus-like particles protects from autoimmune arthritis. Eur. J. Immunol. 38, 877-887.
7. Hertz, M., Mahalingam, S., Dalum, I., Klysner, S., Mattes, J., Neisig, A, Mouritsen, S., Foster, P. S., Gautam, A. (2001) Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J. Immunol. 167, 3792-3799.
8. Hertz, M., Mahalingam, S., Dalum, I., Klysner, S., Mattes, J., Neisig, A, Mouritsen, S., Foster, P. S., Gautam, A (2000) Anti-IL-9 vaccination prevents worm expulsion and blood eosino-philia in Trichuris muris -infected mice. Proc. Natl. Acad. Sci. USA 97, 767-772.
9. Uyttenhove, C, Arendse, B., Stroobant, V., Brombacher, F., Van Snick, J. (2004) Development of an anti-IL-12 p40 auto-vaccine: protection in experimental autoimmune encephalomyelitis at the expense of increased sensitivity to infection. Eur. J. Immunol. 34, 3572-3581.
10. Uyttenhove, C, Van Snick, J. (2006) Development of an anti-IL-17A auto-vaccine that prevents experimental auto-immune encephalomyelitis. Eur J. Immunol. 36, 2868-2874.
11. Rad, F. H., Le Buanec, H., Paturance, S., Larcier, P., Genne, P., Ryffel, B., Bensussan, A., Bizzini, B., Gallo, R C, Zagury, D., Uzan, G. (2007) VEGF kinoid vaccine, a therapeutic approach against tumor angiogenesis and metastases. Proc. Natl. Acad. Sci. USA 104, 2837-2842.
12. Zagury, D., Le Buanec, H., Mathian, A, Larcier, P., Burnett, R, Amoura, Z., Emilie, D., Peltre, G., Bensussan, A., Bizzini, B., Gallo, R C, Koutou-zov, S. (2009) IFNα kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model. Proc. Natl. Acad. Sci. USA 106, 5294-5299.
13. Alexander, J., Sidney, J., Southwood, S., Ruppert, J., Oseroff, C, Maewal, A, Snoke, K, Serra, H. M., Kubo, R. T., Sette, A, et al. (1994) Development of high potency universal DR-restricted helper epitopes by modification of high affinity DR-blocking peptides. Immunity 1, 751-761.
14. Nakae, S., Komiyama, Y., Nambu, A, Sudo, K, Iwase, M., Homma, I., Sekikawa, K, Asano, M., Iwakura, Y. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17, 375-387.
15. Derynck, R, Jarrett, J. A, Chen, E. Y, Goeddel, D. V. (1986) The murine transforming growth factor-β precursor. J. Biol. Chem. 261, 4377-4379.
16. Van Coillie, E., Van Aelst, I., Wuyts, A, Vercauteren, R, Devos, R, De Wolf-Peeters, C, Van Damme, J., Opdenakker, G. (2001) Tumor angiogenesis induced by granulocyte chemotactic protein-2 as a countercur-rent principle. Am. J. Pathol. 159, 1405-1414.
17. Masure, S., Nys, G., Fiten, P., Van Damme, J., Opdenakker, G. (1993) Mouse gelatinase B. cDNA cloning, regulation of expression and glycosylation in WEHI-3 macrophages and gene organization. Eur. J. Biochem. 218, 129-141.
18. Struyf, S., Menten, P., Lenaerts, J. P., Put, W., D'Haese, A, De Clercq, E., Schols, D., Proost, P., Van Damme, J. (2001) Diverging binding capacities of natural LD78/3 isoforms of macrophage inflammatory protein-1α to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils. Eur. J. Immunol. 31, 2170-2178.
19. Lopez, A. F., Strath, M., Sanderson, C.J. (1984) Differentiation antigens on mouse eosinophils and neutrophils identified by monoclonal antibodies. Br. J. Haematol. 57, 489-494.
20. Charmoy, M., Auderset, F., Allenbach, C, Tacchini-Cottier, F. (2010) The prominent role of neutrophils during the initial phase of infection by Leishmania parasites. J. Biomed. Biotechnol. 2010, 719361.
21. Dexter, T. M., Garland, J., Scott, D., Scolnick, E., Metcalf, D. (1980) Growth of factor-dependent hemopoietic precursor cell lines. J. Exp. Med. 152, 1036-1047.
22. Landegren, U. (1984) Measurement of cell numbers by means of the endogenous enzyme hexosaminidase. Application to detection of lympho-kines and cell surface antigens. J. Immunol. Methods 67, 379-388.
23. Abe, M., Harpel, J. G., Metz, C. N., Nunes, I., Loskutoff, D. J., Rifkin, D. B. (1994) An assay for transforming growth factor-β using cells trans-fected with a plasminogen activator inhibitor-1 promoter-luciferase construct. Anal. Biochem. 216, 276-284.
24. Batten, M., Li, J., Yi, S., Kljavin, N. M., Danilenko, D. M., Lucas, S., Lee, J., de Sauvage, F. J., Ghilardi, N. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat. Immunol. 7, 929-936.
25. Veldhoen, M., Uyttenhove, C, van Snick, J., Helmby, H., Westendorf, A, Buer, J., Martin, B., Wilhelm, C, Stockinger, B. (2008) Transforming growth factor-β reprograms the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol. 9, 1341-1346.
26. Billiau, A, Heremans, H., Vandekerckhove, F., Dillen, C. (1987) Anti-interferon-7 antibody protects mice against the generalized Shwartzman reaction. Eur. J. Immunol. 17, 1851-1854.
27. Uyttenhove, C, Brombacher, F., Van Snick, J. (2010) TGF-β interactions with IL-1 family members trigger IL-4-independent IL-9 production by mouse CD4(+) T cells. Eur. J. Immunol. 40, 2230-2235.
28. Piccard, H., Hu, J., Fiten, P., Proost, P., Martens, E., Van den Steen, P. E., Van Damme, J., Opdenakker, G (2009) Reverse degradomics, monitoring of proteolytic trimming by multi-CE and confocal detection of fluorescent substrates and reaction products. Electrophoresis 30, 2366-2377.
29. Avrameas, S., Ternynck, T. (1969) The cross-linking of proteins with glu-taraldehyde and its use for the preparation of immunoadsorbents. Immu-nochemistry 6, 53-66.
30. Wuyts, A, Haelens, A, Proost, P., Lenaerts, J. P., Conings, R, Opdenakker, G., Van Damme, J. (1996) Identification of mouse granulocyte chemotactic protein-2 from fibroblasts and epithelial cells. Functional comparison with natural KC and macrophage inflammatory protein-2. J. Immunol. 157, 1736-1743.
31. Charmoy, M., Brunner-Agten, S., Aebischer, D., Auderset, F., Launois, P., Milon, G., Proudfoot, A E., Tacchini-Cottier, F. (2010) Neutrophil-derived CCL3 is essential for the rapid recruitment of dendritic cells to the site of Leishmania major inoculation in resistant mice. PLoS Pathog. 6, e1000755.
32. Fort, M. M., Cheung, J., Yen, D., Li, J., Zurawski, S. M., Lo, S., Menon, S., Clifford, T, Hunte, B., Lesley, R, Muchamuel, T, Hurst, S. D., Zurawski, G., Leach, M. W., Gorman, D. M., Rennick, D. M. (2001) IL-25 induces IL-4, IL-5, and IL-13 and Th2-associated pathologies in vivo. Immunity 15, 985-995.
33. Dasch, J. R., Pace, D. R, Waegell, W., Inenaga, D., Ellingsworth, L. (1989) Monoclonal antibodies recognizing transforming growth factor-β. Bioactivity neutralization and transforming growth factor β 2 affinity purification. J. Immunol. 142, 1536-1541.
34. Opdenakker, G., Nelissen, I., Van Damme, J. (2003) Functional roles and therapeutic targeting of gelatinase B and chemokines in multiple sclerosis. Lancet Neurol. 2, 747-756.
35. Zagury, D., Le Buanec, H., Bizzini, B., Burny, A, Lewis, G., Gallo, R C. (2003) Active versus passive anti-cytokine antibody therapy against cyto-kine-associated chronic diseases. Cytokine Growth Factor Rev. 14, 123-137.